Quantinuum Inc. (NASDAQ:QNT - Get Free Report) reached a new 52-week low on Wednesday . The stock traded as low as $46.65 and last traded at $47.63, with a volume of 102658 shares changing hands. The stock had previously closed at $47.66.
Wall Street Analysts Forecast Growth
QNT has been the subject of a number of analyst reports. Evercore assumed coverage on Quantinuum in a research report on Monday, June 29th. They issued an "outperform" rating and a $98.00 price target for the company. Craig Hallum started coverage on shares of Quantinuum in a research note on Monday, June 29th. They issued a "buy" rating and a $100.00 price target on the stock. Rosenblatt Securities reaffirmed a "buy" rating and issued a $155.00 target price on shares of Quantinuum in a research report on Wednesday, August 19th. Cantor Fitzgerald restated an "overweight" rating and issued a $90.00 price target on shares of Quantinuum in a research note on Wednesday, August 12th. Finally, Wall Street Zen lowered shares of Quantinuum from a "hold" rating to a "sell" rating in a research note on Saturday, July 4th. Eleven investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Quantinuum presently has an average rating of "Moderate Buy" and an average price target of $98.42.
View Our Latest Research Report on Quantinuum
Quantinuum Price Performance
The stock's fifty day simple moving average is $61.52.
Quantinuum (NASDAQ:QNT - Get Free Report) last posted its earnings results on Tuesday, August 11th. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.26) by ($0.02). The business had revenue of $8.00 million during the quarter. On average, research analysts anticipate that Quantinuum Inc. will post -1.64 earnings per share for the current fiscal year.
Insider Transactions at Quantinuum
In other Quantinuum news, Director Hal Barron purchased 250,000 shares of Quantinuum stock in a transaction on Friday, June 5th. The shares were purchased at an average cost of $60.00 per share, with a total value of $15,000,000.00. Following the completion of the transaction, the director directly owned 255,833 shares in the company, valued at approximately $15,349,980. This represents a 4,285.96% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Kevin Scott Dehoff purchased 15,000 shares of the firm's stock in a transaction on Friday, June 5th. The stock was bought at an average price of $60.00 per share, with a total value of $900,000.00. Following the acquisition, the insider owned 126,460 shares in the company, valued at $7,587,600. This trade represents a 13.46% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 411,032 shares of company stock valued at $24,661,920 in the last ninety days.
Institutional Investors Weigh In On Quantinuum
A number of hedge funds have recently added to or reduced their stakes in the stock. Lisanti Capital Growth LLC acquired a new stake in Quantinuum in the second quarter worth about $409,000. Outfitters Financial LLC bought a new position in shares of Quantinuum in the second quarter valued at $511,000. Readystate Asset Management LP purchased a new stake in shares of Quantinuum during the second quarter valued at $4,111,000. Finally, Wellington Management Group LLP purchased a new stake in Quantinuum during the second quarter valued at about $92,418,000.
Quantinuum Company Profile
(
Get Free Report)
Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.
The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Quantinuum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantinuum wasn't on the list.
While Quantinuum currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.